Arbutus Biopharma(ABUS)
$3.88+0.06 (+1.57%)
ABUS
Arbutus Biopharma Revenue
$3.88
At close:+0.06 (+1.57%)
Want to see ABUS full AI Analyst Report?
Arbutus Biopharma (ABUS) Revenue
1,288 Followers
Arbutus Biopharma Revenue
Arbutus Biopharma had a revenue of 299.00K in the quarter ending Sep 30, 2026, with -70.51%. This bring the company's revenue in the last twelve months to 181.49M, Decreased 0.13%. In the fiscal year ending Dec 31, 2025, Arbutus Biopharma had annual revenue of 14.08M with 128.21% growth.
- Revenue (ttm)
- 181.49M
- Revenue Growth
- 1142.57%
- P/S Ratio
- 53.74
- Revenue/Employee
- $741,211
- Employees
- 19
- Market Cap
- $756.76M
Revenue Chart
Arbutus Biopharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.08M | 7.91M | 128.21% |
| Dec 31, 2024 | 6.17M | -11.97M | -65.98% |
| Dec 31, 2023 | 18.14M | -20.88M | -53.51% |
| Dec 31, 2022 | 39.02M | 28.03M | 255.11% |
| Dec 31, 2021 | 10.99M | 4.07M | 58.92% |
| Dec 31, 2020 | 6.91M | 903.00K | 15.02% |
| Dec 31, 2019 | 6.01M | 111.00K | 1.88% |
| Dec 31, 2018 | 5.90M | -4.80M | -44.86% |
| Dec 31, 2017 | 10.70M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.